81574-69-8

Basic information

• Product Name: 2-broMo-4,6-diMethoxybenzaldehyde
• Synonyms: 2-broMo-4,6-diMethoxybenzaldehyde
• CAS NO: 81574-69-8
• Molecular Formula: C₉H₉BrO₃
• Molecular Weight: 245.06996
• EINECS: -0
• Mol File: 81574-69-8.mol
• Article Data: 25

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 2-broMo-4,6-diMethoxybenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-broMo-4,6-diMethoxybenzaldehyde(81574-69-8)
• EPA Substance Registry System: 2-broMo-4,6-diMethoxybenzaldehyde(81574-69-8)

Safety Data

• Hazardous Substances Data: 81574-69-8(Hazardous Substances Data)

Upstream product

• 20469-65-2 1-bromo-3,5-dimethoxybenzene 
• 68-12-2 N,N-dimethyl-formamide 
• 4885-02-3 Dichloromethyl methyl ether 

Downstream Products

• 1144467-77-5 C₉H₁₁BrO₃ 
• 312305-50-3 (S)-2,4-dimethoxy-6-vinyl-benzoic acid 1-methyl-4-(2-pent-4-enyl-[1,3]dioxolan-2-yl)-butyl ester 
• 10497-40-2 2,4-Dimethoxy-zearalenone 
• 17924-92-4 zearalenone 
• 1204755-29-2 4,6-dimethoxy-2-vinyl-benzoic acid 
• 1449688-77-0 2,4-dimethoxy-6-vinylbenzoyl fluoride 
• 91142-86-8 4,6-dimethoxy-2-vinyl-benzaldehyde 
• 1493783-76-8 2,4-dimethoxy-6-(5-fluoro-2-methoxyphenyl)benzaldehyde 

Relevant articles and documents

Construction of Enantiopure Taxoid and Natural Product-like Scaffolds Using a C-C Bond Cleavage/Arylation Reaction

An approach to construct enantiopure complex natural product-like frameworks, including the first reported synthesis of a C17 oxygenated taxoid scaffold, is presented. A palladium-catalyzed C-C activation/cross-coupling is utilized to access these structu

Reinvestigating the acyl cyclization to the precursor of diptoindonesin G

We reinvestigated the synthesis of the precursor of diptoindonesin G (2) by the intramolecular acyl cyclization of compound 1 or compound 3 in the presence of trifluoroacetic anhydride (TFAA) [1,2]. Although the reaction of 3 with TFAA generated 2 smoothl

AROMATIC DERIVATIVES, PREPARATION METHODS, AND MEDICAL USES THEREOF

The present disclosure relates generally to aromatic derivatives that are inhibitors of FGFR4 and are useful in treating FGFR4-associated diseases or conditions. Compositions containing the compounds of the present disclosure are also provided.